Clifford Courville, MD
Pulmonary Disease · Lake Charles, LANPI 1942461207
Payments from drug & device makers
Across 612 payments — averaging $23.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$3K
- Intuitive Surgical$3K
- AstraZeneca$1K
- Boehringer Ingelheim$901
- Sanofi$746
- Regeneron Healthcare Solutions, Inc.$516
- plus $5K from 35 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 209 | $3,403 |
| Intuitive Surgical | 12 | $3,394 |
| AstraZeneca | 57 | $1,038 |
| Boehringer Ingelheim | 39 | $901 |
| Sanofi | 42 | $746 |
| Regeneron Healthcare Solutions, Inc. | 23 | $516 |
| CSL Behring | 21 | $463 |
| Insmed, Inc. | 18 | $460 |
| Baxter Healthcare | 12 | $365 |
| Sunovion Pharmaceuticals Inc. | 31 | $342 |
| Actelion Pharmaceuticals US, Inc. | 18 | $307 |
| Novartis | 13 | $267 |
| Amgen | 12 | $263 |
| United Therapeutics Corporation | 12 | $232 |
| Grifols USA, LLC | 13 | $231 |
| Philips North America LLC | 15 | $231 |
| Mylan Specialty L.p. | 12 | $191 |
| Genentech USA, Inc. | 10 | $169 |
| Sanofi-aventis U.S. LLC | 2 | $159 |
| Verona Pharma, Inc. | 5 | $117 |
| Gilead | 6 | $105 |
| Bayer | 5 | $98 |
| Covidien LP | 1 | $86 |
| ANI Pharmaceuticals, Inc. | 2 | $56 |
| Viatris Specialty LLC | 2 | $48 |
| Pfizer | 3 | $41 |
| Pulmonx Corporation | 2 | $39 |
| Vifor Pharma, Inc. | 1 | $26 |
| Abiomed | 1 | $25 |
| Johnson & Johnson | 2 | $24 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Merck | 1 | $20 |
| Tactile Systems Technology Inc | 1 | $19 |
| Electromed, Inc. | 1 | $17 |
| Advanced Respiratory, Inc | 1 | $16 |
| AbbVie | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Circassia Inc. | 1 | $13 |
| Haemonetics Corporation | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
How this compares
$14,524 in reported general payments places this provider in the 75th percentile of 189 pulmonary disease providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Lake Charles
- Gary KohlerLake Charles$21K
- Luke WilliamsLake Charles$16K
- Robert BroussardLake Charles$15K
- Tashfeen MahmoodLake Charles$14K
- David GreenShreveport$2M
- Joseph LaskyNew Orleans$1.9M
- Leonardo SeoaneNew Orleans$1.6M
- Ross KlingsbergNew Orleans$1.2M
- Juzar AliNew Orleans$775K
- Hollis O NealBaton Rouge$682K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.